Can a simple enema prevent radiation damage during rectal cancer treatment?

NCT ID NCT07548736

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether a daily dexamethasone enema can prevent or reduce acute rectal injury in 40 rectal cancer patients undergoing pelvic radiotherapy. One group starts the enema early (day 10 of radiation), while the other starts only after injury occurs. The goal is to see if early use lowers injury rates and helps patients complete their full radiation course.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexamethasone enema
What this could lead to
If successful, this could provide a simple, low-cost way to prevent or reduce rectal injury during pelvic radiotherapy, helping patients complete their cancer treatment with fewer side effects.
What could go wrong
This is a small, early-phase trial with only 40 participants, so results may not apply to all patients. The treatment is given as an enema, which may be uncomfortable, and dexamethasone can have side effects like irritation or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RADIATION ENTERITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510655, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.